A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients
Gulati, Anil, Choudhuri, Rajat, Gupta, Ajay, Singh, Saurabh, Ali, S. K. Noushad, Sidhu, Gursaran Kaur, Haque, Parvez David, Rahate, Prashant, Bothra, Aditya R., Singh, Gyan P., Maheshwari, Sanjiv, Jeswani, Deepak, Haveri, Sameer, Agarwal, Apurva, Agrawal, Nilesh Radheshyam
Published in Drugs (New York, N.Y.) (01.06.2021)
Published in Drugs (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Abstract 118: Multicentric, Randomized Controlled Phase III Study of Centhaquine (Lyfaquin®) as an Effective First-in-class Resuscitative Agent in Hypovolemic Shock Patients
Gulati, Anil, Choudhuri, Rajat, Gupta, Ajay, Singh, Saurabh, Ali, S. K. Noushad, Sidhu, Gursaran Kaur, Haque, Parvez David, Rahate, Prashant, Bothra, Aditya R., Singh, G.P., Maheshwari, Sanjeev, Jeswani, Deepak, Haveri, Sameer, Agarwal, Apurva, Agrawal, Nilesh Radheshyam
Published in Circulation (New York, N.Y.) (17.11.2020)
Published in Circulation (New York, N.Y.) (17.11.2020)
Get full text
Journal Article
A multicentric, randomized, controlled phase III study of centhaquine (Lyfaquin ® ) as a resuscitative agent in hypovolemic shock patients
Gulati, Anil, Choudhuri, Rajat, Gupta, Ajay, Singh, Saurabh, Noushad Ali, S K, Sidhu, Gursaran Kaur, Haque, Parvez David, Rahate, Prashant, Bothra, Aditya R, Singh, G P, Maheshwari, Sanjeev, Jeswani, Deepak, Haveri, Sameer, Agarwal, Apurva, Agrawal, Nilesh Radheshyam
Published in medRxiv : the preprint server for health sciences (09.05.2021)
Published in medRxiv : the preprint server for health sciences (09.05.2021)
Get more information
Journal Article